Mitogen-Dependent Regulation of DUSP1 Governs ERK and p38 Signaling During Early 3T3-L1 Adipocyte Differentiation

Journal of Cellular Physiology

Volumn 231, Issue 7, 2016, Pages 1562-1574

  Ferguson, Bradley S ^a   Nam, Heesun ^a   Stephens, Jacqueline M ^b   Morrison, Ron F ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 10; DUAL SPECIFICITY PHOSPHATASE 16; DUAL SPECIFICITY PHOSPHATASE 2; DUAL SPECIFICITY PHOSPHATASE 4; DUAL SPECIFICITY PHOSPHATASE 5; DUAL SPECIFICITY PHOSPHATASE 6; DUAL SPECIFICITY PHOSPHATASE 9; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SMALL INTERFERING RNA; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; DUSP1 PROTEIN, MOUSE; MESSENGER RNA;

3T3 CELL LINE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION; MALE; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; GENETICS; HUMAN; METABOLISM; OBESITY; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; OBESITY; PHOSPHORYLATION; RNA, MESSENGER;

EID: 84962493544     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25248     Document Type: Article

References (70)

1. Aouadi M, Jager J, Laurent K, Gonzalez T, Cormont M, Binetruy B, Le Marchand-Brustel Y, Tanti JF, Bost F. 2007. P38MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett 581:5591-5596.
2. Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binetruy B, Bost F. 2006. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55:281-289.
3. Auld CA, Fernandes KM, Morrison RF. 2007. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia. J Cell Physiol 211:101-111.
4. Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, Maassen JA. 2004. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 18:1697-1707.
5. Belmonte N, Phillips BW, Massiera F, Villageois P, Wdziekonski B, Saint-Marc P, Nichols J, Aubert J, Saeki K, Yuo A, Narumiya S, Ailhaud G, Dani C. 2001. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes. Mol Endocrinol 15:2037-2049.
6. Bennett AM, Tonks NK. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291.
7. Bjorntorp P, Karlsson M, Pettersson P. 1982. Expansion of adipose tissue storage capacity at different ages in rats. Metabolism 31:366-373.
8. Bost F, Aouadi M, Caron L, Binetruy B. 2005a. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87:51-56.
9. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, Dani C, Hofman P, Pages G, Pouyssegur J, Le Marchand-Brustel Y, Binetruy B. 2005b. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54:402-411.
10. Bouchard L, Tchernof A, Deshaies Y, Marceau S, Lescelleur O, Biron S, Vohl MC. 2007. ZFP36: A promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg 17:372-382.
11. Chinery R, Brockman JA, Dransfield DT, Coffey RJ. 1997. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. J Biol Chem 272:30356-30361.
12. Cho IJ, Woo NR, Kim SG. 2008. The identification of C/EBPbeta as a transcription factor necessary for the induction of MAPK phosphatase-1 by toll-like receptor-4 ligand. Arch Biochem Biophys 479:88-96.
13. Datta NS, Kolailat R, Fite A, Pettway G. Abou-Samra AB (2010). Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Cell Signal 22:457-466.
14. Dickinson RJ, Keyse SM. 2006. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119:4607-4615.
15. Djian P, Phillips M, Green H. 1985. The activation of specific gene transcription in the adipose conversion of 3T3 cells. J Cell Physiol 124:554-556.
16. Ebisuya M, Kondoh K, Nishida E. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity: Mechanisms for providing signaling specificity. J Cell Sci 118:2997-3002.
17. Emanuelli B, Eberle D, Suzuki R, Kahn CR. 2008. Overexpression of the dual-specificity phosphatase MKP-4/DUSP-9 protects against stress-induced insulin resistance. Proc Natl Acad Sci USA 105:3545-3550.
18. Engelman JA, Berg AH, Lewis RY, Lin A, Lisanti MP, Scherer PE. 1999. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. J Biol Chem 274:35630-35638.
19. Engelman JA, Lisanti MP, Scherer PE. 1998. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273:32111-32120.
20. Faust IM, Johnson PR, Stern JS, Hirsch J. 1978. Diet-induced adipocyte number increase in adult rats: A new model of obesity. Am J Physiol 235:E279-E286.
21. Feng B, Jiao P, Helou Y, Li Y, He Q, Walters MS, Salomon A, Xu H. 2014. MAP kinase phosphatase 3 (MKP-3) deficient mice are resistant to diet induced-obesity. Diabetes 63:2924-2934.
22. Ferguson BS, Nam H, Hopkins RG, Morrison RF. 2010. Impact of reference gene selection for target gene normalization on experimental outcome using real-time qRT-PCR in adipocytes. PLoS ONE 5:e15208.
23. Gorzelniak K, Janke J, Engeli S, Sharma AM. 2001. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm Metab Res 33:625-627.
24. Gregor MF, Hotamisligil GS. 2011. Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415-445.
25. Guenard F, Bouchard L, Tchernof A, Deshaies Y, Hould FS, Lebel S, Marceau P, Perusse L, Vohl MC. 2013. DUSP1 Gene polymorphisms are associated with obesity-related metabolic complications among severely obese patients and impact on gene methylation and expression. Int J Genomics 2013:609748.
26. Haslam DW, James WP. 2005. Obesity. Lancet 366:1197-1209.
27. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. 2001. The biology of white adipocyte proliferation. Obes Rev 2:239-254.
28. Hirsch J, Batchelor B. 1976. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5:299-311.
29. Hirsch J, Fried SK, Edens NK, Leibel RL. 1989. The fat cell. Med Clin North Am 73:83-96.
30. Hu E, Kim JB, Sarraf P, Spiegelman BM. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100-2103.
31. Huai Q, Wang H, Zhang W, Colman RW, Robinson H, Ke H. 2004. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc Natl Acad Sci USA 101:9624-9629.
32. Jeffrey KL, Camps M, Rommel C, Mackay CR. 2007. Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6:391-403.
33. Johansson-Haque K, Palanichamy E, Okret S. 2008. Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J Mol Endocrinol 41:239-249.
34. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. 2001. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20:7108-7116.
35. Keyse SM. 2008. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 27:253-261.
36. Khadir A, Tiss A, Abubaker J, Abu-Farha M, Al-Khairi I, Cherian P, John J, Kavalakatt S, Warsame S, Al-Madhoun A, Al-Ghimlas F, Elkum N, Behbehani K, Dermime S, Dehbi M. 2015. MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise. Am J Physiol Endocrinol Metab 308:E71-E83.
37. Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP. 1979. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest 63:239-246.
38. Kondoh K, Nishida E. 2007. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 1773:1227-1237.
39. Kusari AB, Byon J, Bandyopadhyay D, Kenner KA, Kusari J. 1997. Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: A mechanism for the feedback inhibition of insulin signaling. Mol Endocrinol 11:1532-1543.
40. Liu Q. 2011. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol 11:377-383.
41. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
42. Mandenoff A, Lenoir T, Apfelbaum M. 1982. Tardy occurrence of adipocyte hyperplasia in cafeteria-fed rat. Am J Physiol 242:R349-R351.
43. Matsuguchi T, Chiba N, Bandow K, Kakimoto K, Masuda A, Ohnishi T. 2009. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation. J Bone Miner Res 24:398-410.
44. Morrison RF, Farmer SR. 1999a. Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem S32-33:59-67.
45. Morrison RF, Farmer SR. 1999b. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J Biol Chem 274:17088-17097.
46. Morrison RF, Farmer SR. 2000. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr 130:3116S-3121S.
47. Park BH, Qiang L, Farmer SR. 2004. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Mol Cell Biol 24:8671-8680.
48. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
49. Prusty D, Park BH, Davis KE, Farmer SR. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-46232.
50. Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM. 2004. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol 24:1676-1681.
51. Reffas S, Schlegel W. 2000. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem J 352:701-708.
52. Rosen ED, Spiegelman BM. 2000. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-171.
53. Sakaue H, Ogawa W, Nakamura T, Mori T, Nakamura K, Kasuga M. 2004. Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation. J Biol Chem 279:39951-39957.
54. Sale EM, Atkinson PG, Sale GJ. 1995. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14:674-684.
55. Schliess F, Kurz AK, Haussinger D. 2000. Glucagon-induced expression of the MAP kinase phosphatase MKP-1 in rat hepatocytes. Gastroenterology 118:929-936.
56. Schroder K, Wandzioch K, Helmcke I, Brandes RP. 2009. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler Thromb Vasc Biol 29:239-245.
57. Stephens JM, Butts MD, Pekala PH. 1992. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J Mol Endocrinol 9:61-72.
58. Stephens JM, Pekala PH. 1992. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. J Biol Chem 267:13580-13584.
59. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, DeFuria J, Jick Z, Greenberg AS, Obin MS. 2007. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56:2910-2918.
60. Tanaka T, Yoshida N, Kishimoto T, Akira S. 1997. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 16:7432-7443.
61. Tang QQ, Otto TC, Lane MD. 2003. Mitotic clonal expansion: A synchronous process required for adipogenesis. Proc Natl Acad Sci USA 100:44-49.
62. Tanoue T, Nishida E. 2003. Molecular recognitions in the MAP kinase cascades. Cell Signal 15:455-462.
63. Torti FM, Torti SV, Larrick JW, Ringold GM. 1989. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol 108:1105-1113.
64. Wu JJ, Roth RJ, Anderson EJ, Hong EG, Lee MK, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM. 2006. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 4:61-73.
65. Wu Z, Bucher NL, Farmer SR. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 16:4128-4136.
66. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. 2003a. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830.
67. Xu H, Dembski M, Yang Q, Yang D, Moriarty A, Tayber O, Chen H, Kapeller R, Tartaglia LA. 2003b. Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance. J Biol Chem 278:30187-30192.
68. Yang SP, Martin LJ, Schneider G. 1980. Weight reduction utilizing a protein-sparing modified fast. J Am Diet Assoc 76:343-346.
69. Zhang X, Ji J, Yan G, Wu J, Sun X, Shen J, Jiang H, Wang H. 2010. Sildenafil promotes adipogenesis through a PKG pathway. Biochem Biophys Res Commun 396:1054-1059.
70. Zhang Y, Dong C. 2007. Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci 64:2771-2789.